The comprehensive evaluation of clinical trials designed to investigate FSH efficacy in male idiopathic infertility showed an overall increased pregnancy rate after treatment, burdened by a high number-need-to-treat to obtain a single pregnancy [4, 5]. This evidence concerns the gene BRD2 and male infertility.